Quick Answer
Bipolar disorder involves episodes of mania and depression. Learn about the diagnostic subtypes, how episodes present, and what treatments help stabilize mood.
Medically reviewed by Dr. Ruja Shrestha • NMC 19766 • Kathmandu Neurology Clinic & Cognitive Center
Bipolar disorder is a chronic mental health condition characterized by episodic disturbances in mood, energy, activity levels, and the ability to carry out daily tasks. It involves recurrent episodes of mania (or hypomania) and depression, with periods of relative stability between episodes. According to the World Health Organization, bipolar disorder affects approximately 46 million people worldwide.
The DSM-5 recognizes two primary subtypes. Bipolar I Disorder is defined by the occurrence of at least one manic episode, which may be preceded or followed by hypomanic or major depressive episodes. A manic episode is a distinct period of abnormally and persistently elevated, expansive, or irritable mood and increased activity or energy lasting at least seven days (or any duration if hospitalization is required). During this period, the individual exhibits increased goal-directed activity, pressured speech, flight of ideas, distractibility, decreased need for sleep, grandiosity, and increased risky behavior (spending sprees, sexual indiscretions, foolish business investments). The mood disturbance must cause marked impairment in functioning or necessitate hospitalization.
Dr. Ruja Shrestha — consultant psychiatrist & cbt therapist at Kathmandu Neurology Clinic & Cognitive Center provides evidence-based evaluation for major depressive disorder.
Bipolar II Disorder involves a pattern of at least one hypomanic episode and at least one major depressive episode, without a full manic episode. Hypomania is a less severe form of mania lasting at least four consecutive days, with symptoms similar to mania but of lesser intensity and without the severe functional impairment, psychotic features, or need for hospitalization that characterize full mania.
Cyclothymic Disorder involves chronic fluctuating mood disturbance involving numerous hypomanic and depressive symptoms that do not meet criteria for a hypomanic or depressive episode, persisting for at least two years.
Depressive episodes in bipolar disorder are clinically similar to those in Major Depressive Disorder and involve depressed mood, anhedonia, sleep and appetite changes, fatigue, feelings of worthlessness, difficulty concentrating, and recurrent thoughts of death or suicide. Distinguishing bipolar depression from unipolar depression is clinically important because the treatment approaches differ — antidepressant monotherapy can potentially trigger manic switching in bipolar disorder.
Mixed episodes, in which criteria for both manic and depressive episodes are met simultaneously, are also recognized and are associated with increased risk of suicide and functional impairment.
The course of bipolar disorder is variable. Some individuals experience predominantly depressive episodes, others predominantly manic, and many experience a mixed pattern. Episode frequency varies — some individuals have several episodes per year, while others have extended periods of stability. Longitudinal studies suggest that a significant proportion of the illness course is spent in depressive episodes, and depression is the primary driver of disability and suicide risk in bipolar disorder.
Neurobiological research implicates dysregulation of monoamine neurotransmitter systems, circadian rhythm disruption, neuroinflammatory processes, and structural and functional brain changes in bipolar disorder. Genetic factors play a substantial role, with heritability estimates of approximately 80 percent. First-degree relatives of individuals with bipolar disorder have a significantly elevated risk of developing the condition.
Mood stabilizers are the pharmacological cornerstone of bipolar disorder treatment. Lithium has the longest evidence base and is the only medication with demonstrated anti-suicide properties. Anticonvulsants such as valproate and lamotrigine are used for mood stabilization — valproate is particularly effective for rapid-cycling and manic presentations, while lamotrigine is more effective for bipolar depression. Atypical antipsychotics (quetiapine, olanzapine, aripiprazole, lurasidone) are also used for acute episodes and maintenance.
Psychotherapy is an important adjunct to pharmacotherapy. Psychoeducation — helping individuals and families understand the illness, recognize early warning signs, and adhere to treatment — is fundamental. CBT adapted for bipolar disorder can help with mood monitoring, identifying triggers, and managing cognitive distortions during episodes. Interpersonal and Social Rhythm Therapy (IPSRT) focuses on stabilizing daily routines and interpersonal relationships to reduce episode triggers.
In Nepal, bipolar disorder is frequently misdiagnosed or diagnosed late. Families may initially attribute manic symptoms to improved mood or personality changes rather than recognizing a pathological state. Cultural and spiritual interpretations of dramatic mood changes can delay appropriate treatment. Long-term medication adherence is a significant challenge due to side effects, cost, stigma, and misconceptions about medication dependence. Ensuring access to lithium level monitoring is an important practical consideration.
This article is educational and does not replace individual medical advice. If you or a family member may be experiencing symptoms suggestive of bipolar disorder, consult a qualified mental health professional for assessment.
**Frequently Asked Questions**
Q: What triggers bipolar episodes? A: Triggers vary but commonly include sleep deprivation, substance use, significant life stress, seasonal changes, and disrupted routines. Some episodes appear to occur without an identifiable trigger. Recognizing personal patterns through mood charting can help with early intervention.
Q: Can bipolar disorder be managed without medication? A: While psychotherapy and lifestyle modifications are important components of treatment, the evidence strongly supports medication as a necessary component for most individuals with bipolar disorder. Stopping medication without medical guidance carries a high risk of relapse.
Q: Is bipolar disorder the same as having mood swings? A: No. Bipolar disorder involves discrete, prolonged episodes of mania or hypomania and depression, separated by periods of relative normalcy. Everyday mood fluctuations are much briefer, less intense, and do not reach the severity or duration criteria for bipolar disorder episodes.
Frequently asked questions
Answers reviewed by Dr. Jitendra Prasad Yadav • MBBS, MD (Internal Medicine), FICN (Neurology), FCNV, FIHM • NMC 8029
Clinical sadness is a normal, transient response to life events. MDD involves persistent symptoms (two or more weeks) that significantly impair daily functioning and quality of life.
Antidepressants (SSRIs, SNRIs) are not addictive, but discontinuation symptoms can occur if stopped abruptly. Tapering under medical supervision is recommended.
Migraine is a neurological condition; headache is one feature. Associated symptoms and functional impact are important for diagnosis.
Aura refers to visual, sensory, or speech symptoms that precede the headache in some people. Both types are migraine; the presence of aura may influence management discussion.
More: All FAQs → · Ask Dr. Jitendra →
Related articles
Recognizing Depression: Signs, Symptoms, and When to Seek Help
How to identify the signs and symptoms of major depressive disorder, understand its impact on daily functioning, and recognize when professional support may be beneficial.
Men's Mental Health: Breaking the Silence Around Masculinity and Emotional Wellbeing
Understanding why men are less likely to seek mental health support, the mental health conditions that disproportionately affect men, and how barriers to care can be addressed.
Addiction and Recovery: Understanding Substance Use Disorders and the Path Forward
An overview of substance use disorders — how addiction develops, its neurological basis, evidence-based treatments, and the role of sustained recovery support.
Medical Disclaimer
Content on this website is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified healthcare professional. Always seek the advice of your physician or other qualified provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this website. In case of a medical emergency, contact emergency services immediately. No doctor–patient relationship is established by use of this site or by contacting the clinic through the site.
References & Review
Reviewed by Dr. Jitendra Prasad Yadav • Last reviewed: 2026-09-04
- International Classification of Headache Disorders, 3rd edition (ICHD-3).
- Harrison's Principles of Internal Medicine — Neurology sections.
- American Academy of Neurology guidelines for selected conditions (where applicable).
Content is educational and aligns with standard medical references; individual evaluation may vary. External links provide context and do not imply endorsement.